Pharmaceutical Research and Manufacturers of America v. United States Department of Health and Human Services

Re Document Nos.: 3, 24, 25, 26 29, 32

MEMORANDUM OPINION

Granting Plaintiff’s Motion for an Injunction; Granting Plaintiff’s Motion for Summary Judgment; and Disposing of all Other Pending Motions in this Case

RUDOLPH CONTRERAS, United States District Judge

I. INTRODUCTION

Orphan drugs are drugs that treat rare diseases or conditions, and are so-named because efforts to research, invest in, and produce them would otherwise be abandoned if not for the incentives Congress has provided pharmaceutical manufacturers to do so. While orphan drugs can only be designated as such to treat rare diseases or…